Prot #PLX-PAD 1204-01: A Phase II, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel-Groups Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogeneic PLX-PAD Cells for the Treatment of Subjects wi

Project: Research project

Project Details

StatusActive
Effective start/end date5/11/155/11/21

Funding

  • Pluristem Ltd. (Prot #PLX-PAS-1204-01)